MCK:NYE-McKesson Corporation (USD)

COMMON STOCK | Medical Distribution |

Last Closing

USD 508

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.46M

Analyst Target

USD 185.31
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-22 )

Largest Industry Peers for Medical Distribution

Symbol Name Price(Change) Market Cap
COR Cencora Inc.

N/A

USD 44.41B
CAH Cardinal Health Inc

N/A

USD 26.96B
OMI Owens & Minor Inc

N/A

N/A
NVG Nuveen AMT Free Municipal Cred..

N/A

N/A

ETFs Containing MCK

BGU:CA Bristol Gate Concentrated.. 5.05 % 0.85 %

N/A

CAD 0.12B
DBPD:XETRA Xtrackers ShortDAX x2 Dai.. 4.88 % 0.00 %

N/A

USD 0.13B
CFCV 4.16 % 0.00 %

N/A

N/A
XYLP:LSE Global X S&P 500® Covere.. 4.10 % 0.00 %

N/A

N/A
WHCS:SW iShares MSCI World Health.. 3.15 % 0.00 %

N/A

N/A
CBUF:F iShares V Public Limited .. 3.08 % 0.00 %

N/A

N/A
CBUF:XETRA iShares MSCI World Health.. 2.64 % 0.00 %

N/A

USD 1.13B
STPL:CA BMO Global Consumer Stapl.. 2.30 % 0.40 %

N/A

CAD 0.04B
POWA Invesco Bloomberg Pricing.. 2.11 % 0.00 %

N/A

N/A
BMVP Invesco Bloomberg MVP Mul.. 2.11 % 0.00 %

N/A

N/A
XLVE:CA Mulvihill U.S. Health Car.. 1.73 % 0.00 %

N/A

N/A
XDEB:SW Xtrackers MSCI World Mini.. 1.48 % 0.00 %

N/A

N/A
MVEW:XETRA iShares Edge MSCI World M.. 1.41 % 0.00 %

N/A

USD 0.78B
MVEC:SW iShares Edge MSCI World M.. 1.41 % 0.00 %

N/A

USD 0.17B
MVEW:SW iShares Edge MSCI World M.. 1.41 % 0.00 %

N/A

USD 0.61B
MVWE:SW iShares Edge MSCI World M.. 1.41 % 0.00 %

N/A

USD 0.07B
SXR0:F iShares VI Public Limited.. 1.28 % 0.00 %

N/A

N/A
SXR0:XETRA iShares Edge MSCI World M.. 1.28 % 0.00 %

N/A

USD 0.09B
UEEH:XETRA iShares Edge MSCI World M.. 1.28 % 0.00 %

N/A

USD 0.03B
MVOL:SW iShares Edge MSCI World M.. 1.28 % 0.00 %

N/A

USD 3.04B
MVSH:SW iShares Edge MSCI World M.. 1.28 % 0.00 %

N/A

USD 0.04B
XDEB:F db x-trackers MSCI World .. 1.28 % 0.00 %

N/A

USD 0.45B
XDEB:XETRA db x-trackers MSCI World .. 1.28 % 0.00 %

N/A

USD 0.42B
DEF 0.00 % 0.59 %

N/A

N/A
DEUS Xtrackers Russell US Mult.. 0.00 % 0.18 %

N/A

USD 0.17B
EZY 0.00 % 0.38 %

N/A

N/A
FLAG 0.00 % 1.52 %

N/A

N/A
ONEO SPDR® Russell 1000 Momen.. 0.00 % 0.20 %

N/A

N/A
CLRG 0.00 % 0.25 %

N/A

N/A
BVNSC 0.00 % 0.00 %

N/A

N/A
RTH VanEck Retail ETF 0.00 % 0.35 %

N/A

N/A
RWL Invesco S&P 500 Revenue E.. 0.00 % 0.39 %

N/A

N/A
RYH 0.00 % 0.40 %

N/A

N/A
SPYB 0.00 % 0.35 %

N/A

N/A
SYV 0.00 % 0.60 %

N/A

N/A
MINV:LSE iShares VI Public Limited.. 0.00 % 0.00 %

N/A

N/A
MVOL:LSE iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
XSD2:LSE db x-trackers ShortDAX x2.. 0.00 % 0.00 %

N/A

USD 0.14B
XDEB:LSE db x-trackers MSCI World .. 0.00 % 0.00 %

N/A

N/A
IQQ0:F iShares Edge MSCI World M.. 0.00 % 0.00 %

N/A

N/A
BLOV:CA Brompton North American L.. 0.00 % 0.00 %

N/A

CAD 0.01B
TDVG T. Rowe Price Dividend Gr.. 0.00 % 0.00 %

N/A

USD 0.70B
BGU-U:CA Bristol Gate Concentrated.. 0.00 % 0.00 %

N/A

CAD 0.11B

Market Performance

  Market Performance vs. Industry/Classification (Medical Distribution) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.72% 40% F 57% F
Dividend Return 0.27% 25% F 5% F
Total Return 9.99% 40% F 49% F
Trailing 12 Months  
Capital Gain 15.81% 40% F 54% F
Dividend Return 0.42% 25% F 4% F
Total Return 16.23% 40% F 46% F
Trailing 5 Years  
Capital Gain 262.06% 100% F 96% N/A
Dividend Return 7.02% 40% F 22% F
Total Return 269.08% 100% F 96% N/A
Average Annual (5 Year Horizon)  
Capital Gain 38.32% 80% B- 92% A
Dividend Return 39.25% 80% B- 92% A
Total Return 0.93% 40% F 21% F
Risk Return Profile  
Volatility (Standard Deviation) 19.60% 60% D- 52% F
Risk Adjusted Return 200.24% 100% F 100% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

High dividend returns

The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.